David I. Quinn, M.B.B.S., Ph.D., F.R.A.C.P., is the Medical Director of the Norris Cancer Hospital, Head, section of Genitourinary Medical Oncology, and Associate Professor of Medicine in the Division of Oncology, Keck School of Medicine of USC. He serves as the Advanced Prostate Cancer Chair of the GU Committee and on the Professional Review Committee of SWOG. Dr. Quinn is also Chair of the GU Program for the California Cancer Consortium, a member of the NCI Task Force for Renal Cancer, and Department of Defense Prostate Cancer Integration Panel.
Dr. Quinn is a graduate of the University of New South Wales Medical School in Sydney, Australia, where he graduated with bachelor of medicine, bachelor surgery with first class honors (M.D. cum laude equivalent) and the Foundation Year Graduates Medal for Leadership and Fellowship by a Graduating Student During the Medical Course. He took residency and fellowship training for the Royal Australasian College of Physicians in internal medicine, medical oncology and clinical pharmacology at St. Vincentís Hospital in Sydney, Australia. He then moved to the Garvan Institute of Medical Research where he completed a doctoral thesis on oncogenes and tumor suppressor genes as biomarkers of outcome in prostate cancer. In 2000, he moved to the USC Norris Comprehensive Cancer Center.
As a physician-scientist his focus is on biomarkers and clinical trials in genitourinary cancers. Dr. Quinnís work defined several key determinants of outcome in localized prostate cancer leading to the first gene chip analysis. Subsequently he focused on Phase I, II and III clinical trials design with incorporation of tumor tissue, circulating and imaging biomarkers.